Fate Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Fate Therapeutics Inc
CIK #0001434316
EDGAR Form CIK 2011 - 2026
10-K [0001434316]
10-Q [0001434316]
3 [0001434316]
4 [0001434316]
8-K [0001434316]
D [0001434316]
SC 13D [0001434316]
SC 13G [0001434316]
Form 13D/13G Filer Form 13D/13G Subject Filed
Schonfeld Strategic Advisors LLC Fate Therapeutics Inc [2025-05-15]
Goldman Sachs Group Inc Fate Therapeutics Inc [2025-05-09]
Boxer Capital LLC Fate Therapeutics Inc [2024-02-12]
Point72 Asset Management LP Fate Therapeutics Inc [2024-01-25]
Millennium Management LLC Fate Therapeutics Inc [2023-03-22]
Capital World Investors Fate Therapeutics Inc [2023-02-13]
State Street Corp Fate Therapeutics Inc [2023-02-03]
Ark Investment Management LLC Fate Therapeutics Inc [2021-09-10]
Vanguard Group Inc Fate Therapeutics Inc [2021-02-10]
Victory Capital Management Inc Fate Therapeutics Inc [2020-01-31]
View All
Form 3/4/5 Subject 2011 - 2026
Fate Therapeutics Inc
Rastetter William H
Epstein Robert S
Agarwal Shefali
Hamill Laura
Abernethy Matt
Lee Michael Stewart
Redmile Group LLC
Green Jeremy
Xu Yuan
Jooss Karin
Valamehr Bahram
Tahl Cindy
RedCo II Master Fund LP
Adawi Kamal
Mozaffarian Neelufar
Mendlein John
Bressi Jerome Charles
Coughlin Timothy
Dulac Edward J III
Wolchko J Scott
Powl Brian T
Hershberg Robert
Chu Yu-Waye
Plavsic Mark
Shoemaker Daniel D
Nashat Amir
Abbot Stewart
Storgard Chris
Enyedy Mark J
Weyer Christian
Flynn Peter D
Multani Pratik S
Venrock Entrepreneurs Fund V LP
Venrock Associates V LP
Venrock Management V LLC
Venrock Partners Management V LLC
VEF Management V LLC
Venrock Partners V L P
Bybee Clinton
Arch Venture Partners VI LP
Arch Venture Fund VI LP
Arch Venture Partners VI LLC
Crandell Keith
Polaris Venture Partners Entrepreneurs' Fund V LP
Polaris Venture Partners V LP
Polaris Venture Partners Special Founders' Fund V LP
Polaris Venture Management Co V LLC
Polaris Venture Partners Founders' Fund V LP
OVP VII Entrepreneurs Fund LP
OVP Venture Partners VII LP
Nelsen Robert
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Fate Therapeutics Inc FATE
Common Stock
2026-01-15 Grant 25,000 $0.00
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
2026-01-15 Grant 75,000 $0.00
Fate Therapeutics Inc FATE
Common Stock
2026-01-15 Grant 100,000 $0.00
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
2026-01-15 Grant 1,300,000 $0.00
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
2026-01-15 Grant 400,000 $0.00
Fate Therapeutics Inc FATE
Common Stock
2026-01-15 Grant 335,000 $0.00
Fate Therapeutics Inc FATE
Common Stock
2026-01-09 Sell 5,190 $1.07 5,553
Fate Therapeutics Inc FATE
Common Stock
2026-01-09 Sell 10,589 $1.06 11,224
Fate Therapeutics Inc FATE
Common Stock
2025-10-20 Grant 75,000 $0.00
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
2025-10-20 Grant 375,000 $0.00
Fate Therapeutics Inc FATE
Common Stock
2025-08-04 Sell 14,466 $1.06 15,334
Fate Therapeutics Inc FATE
Common Stock
2025-08-04 Sell 9,037 $1.06 9,579
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
2025-05-29 Grant 55,000 $0.00
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
2025-05-29 Grant 55,000 $0.00
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
2025-05-29 Grant 55,000 $0.00
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
2025-05-29 Grant 55,000 $0.00
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
2025-05-29 Grant 55,000 $0.00
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
2025-05-29 Grant 55,000 $0.00
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
2025-05-29 Grant 55,000 $0.00
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
2025-05-29 Grant 55,000 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com